Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repligen Corp (NASDAQ:RGEN)

31.35
Delayed Data
As of 3:59pm ET
 +0.34 / +1.10%
Today’s Change
20.07
Today|||52-Week Range
37.88
+10.82%
Year-to-Date
These 3 Stocks Are Up Over 700% in the Last 5 Years
Aug 23 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close31.01
Today’s open30.94
Day’s range30.00 - 31.57
Volume226,948
Average volume (3 months)282,368
Market cap$1.0B
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)+57.14%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+31.45%
P/E ratio130.6
Price/Sales11.37
Price/Book8.32

Competitors

 Today’s
change
Today’s
% change
SUPNSupernus Pharmaceuti...+0.72+3.37%
INSYINSYS Therapeutics I...+0.19+1.27%
MGNXMacroGenics Inc+0.74+2.53%
CEMPCempra Inc+0.22+1.04%
Data as of 3:59pm ET, 08/26/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)$0.08
Annual revenue (last year)$83.5M
Annual profit (last year)$9.3M
Net profit margin11.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts

Partner Offers

Search for Jobs